Acceptability and Tolerance Study of a Thickener
NCT05026476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21
Last updated 2024-11-06
Summary
This is a prospective, acceptability study to evaluate the gastrointestinal tolerance and compliance of a thickener for the management of reflux, GORD and dysphagia
Conditions
Interventions
- DIETARY_SUPPLEMENT
-
Resource Thicken up Junior
Each infant and child will be switch over to receive for a period of 7 days (new thickener)
Sponsors & Collaborators
-
Société des Produits Nestlé (SPN)
lead INDUSTRY
Principal Investigators
-
Analou Sugar · Chelsea and Westminster
Eligibility
- Min Age
- 6 Months
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-16
- Primary Completion
- 2023-03-01
- Completion
- 2023-03-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Topical Bethanechol for Improvement of Esophageal Dysmotility
NCT01031043 ·Status: COMPLETED ·Phase: PHASE1
-
A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice
NCT07004439 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
IDDSI Nutritional Drink for Dysphagia Study
NCT03679078 ·Status: SUSPENDED ·Phase: NA
-
Mirabegron in Achalasia: A Clinical and Manometric Proof of Concept Pilot Study
NCT03411252 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease
NCT06215794 ·Status: WITHDRAWN ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease
NCT06328205 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Clinical Applications of Domperidone in Patients With Delayed Gastric Emptying
NCT01844622 ·Status: COMPLETED ·Phase: NA
-
A Study to Determine the Effectiveness of Endoscopic Full-Thickness Plication for the Treatment of GERD
NCT00575822 ·Status: TERMINATED ·Phase: NA
-
Topical Pharyngeal Anesthesia in Sedated Esophagogastroduodenoscopy
NCT03070379 ·Status: UNKNOWN ·Phase: NA
-
Stellate Ganglion Block on Gastroesophageal Reflux Disease
NCT06319521 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Efficacy of Capsaicin Sensitivity Testing in Patients With Irritable Larynx Syndrome
NCT02065128 ·Status: WITHDRAWN
-
Post-Market Registry for the Evaluation of RefluxStop in GERD Treatment
NCT05870163 ·Status: RECRUITING
-
Improving Diagnostic Standards in Dysphagia
NCT04773184 ·Status: COMPLETED
-
Effect of Lidocaine Block on Gastroesophageal Reflux Disease
NCT06304142 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sensorimotor Dysfunction in Achalasia
NCT02434991 ·Status: WITHDRAWN ·Phase: NA
-
Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux
NCT00414856 ·Status: COMPLETED ·Phase: PHASE1
-
Medical and Surgical Treatment of Esophageal Reflux
NCT00061724 ·Status: COMPLETED
-
Phase 3 Study of JP-1366: Efficacy and Safety of JP-1366 in Patients With Non-erosive Gastroesophageal Reflux Disease
NCT07160790 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Dysphagia Symptom Severity and Quality of Life
NCT03241615 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Non-Erosive Reflux Disease
NCT05587322 ·Status: COMPLETED ·Phase: PHASE3
-
Lingual Tonsil Hypertrophy Grading and Its Relation to Sociodemographic Factors and Clinical Symptoms
NCT02926014 ·Status: COMPLETED ·Phase: NA
-
Phase 3/Safety & Efficacy of Esomeprazole in Infants
NCT00468559 ·Status: COMPLETED ·Phase: PHASE3
-
Multi-Center Study of the NDO Surgical Plicator Utilizing Multiple Implants for the Treatment of GERD
NCT00586859 ·Status: TERMINATED ·Phase: NA
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA